Relieves inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. ANDA 40672, held by Micro Labs. Triamcinolone Acetonide.
As of Nov 15, 2026, ANDA 40672 (Triamcinolone Acetonide), held by Micro Labs, was first approved by FDA on Dec 13, 2006, with 0 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Triamcinolone acetonide lotion, 0.1% is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 13, 2006 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Triamcinolone Acetonide0.1% · lotion;topical | Triamcinolone Acetonide | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
